Correlation between Expressions of Estrogen Receptor, Thymidylate Synthase and CAF Regime Sensibility in Breast Carcinoma

Xiaoli Zhang, Linxi Zhang
{"title":"Correlation between Expressions of Estrogen Receptor, Thymidylate Synthase and CAF Regime Sensibility in Breast Carcinoma","authors":"Xiaoli Zhang, Linxi Zhang","doi":"10.1109/ICBEB.2012.117","DOIUrl":null,"url":null,"abstract":"To study the efficacy of one regimes of commonly used chemotherapy( cyclophosphamide + adriamycin+ 5-fluorouracil, CAF) and its relationship with estrogen receptor(ER), thymidylate synthase (TS) for breast carcinoma. Methods The inhibition rates of CAF with primary cell culture were observed by MTT method in 111 cases of breast carcinoma. The expressions of TS, ER in 111 cases of breast cancer and 38 cases of adenofibroma were examined by streptavidin-perosidase immunohistochemistry method. Results Positive rates of TS and ER were higher in breast carcinoma than that in adenofibroma. Expression of ER was related to histological type in breast carcinoma (P<;0.05). Expressions rates of TS and ER were related to lymph node metastasis (P<;0.05). The sensitive rate of CAF chemotherapy protocols was 44.1%. There was relationship between expressions of TS, ER and sensitive rate of CAF chemotherapy protocols. Conclusion: The overexpressions of TS, ER may play an important role in the carcinogenesis of breast cancer. Detection of TS, ER expressions in breast carcinoma may direct to choose CAF chemotherapy.","PeriodicalId":6374,"journal":{"name":"2012 International Conference on Biomedical Engineering and Biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2012-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2012 International Conference on Biomedical Engineering and Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/ICBEB.2012.117","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

To study the efficacy of one regimes of commonly used chemotherapy( cyclophosphamide + adriamycin+ 5-fluorouracil, CAF) and its relationship with estrogen receptor(ER), thymidylate synthase (TS) for breast carcinoma. Methods The inhibition rates of CAF with primary cell culture were observed by MTT method in 111 cases of breast carcinoma. The expressions of TS, ER in 111 cases of breast cancer and 38 cases of adenofibroma were examined by streptavidin-perosidase immunohistochemistry method. Results Positive rates of TS and ER were higher in breast carcinoma than that in adenofibroma. Expression of ER was related to histological type in breast carcinoma (P<;0.05). Expressions rates of TS and ER were related to lymph node metastasis (P<;0.05). The sensitive rate of CAF chemotherapy protocols was 44.1%. There was relationship between expressions of TS, ER and sensitive rate of CAF chemotherapy protocols. Conclusion: The overexpressions of TS, ER may play an important role in the carcinogenesis of breast cancer. Detection of TS, ER expressions in breast carcinoma may direct to choose CAF chemotherapy.
乳腺癌中雌激素受体、胸腺苷酸合酶表达与CAF敏感性的关系
探讨乳腺癌常用化疗方案环磷酰胺+阿霉素+ 5-氟尿嘧啶(CAF)的疗效及其与雌激素受体(ER)、胸苷酸合成酶(TS)的关系。方法采用MTT法观察111例乳腺癌原代细胞培养对CAF的抑制率。采用链霉亲和素-过氧化物酶免疫组化方法检测111例乳腺癌和38例腺纤维瘤组织中TS、ER的表达。结果TS和ER在乳腺癌中的阳性率高于腺纤维瘤。乳腺癌组织中ER的表达与组织类型有关(P< 0.05)。TS、ER表达率与淋巴结转移相关(P< 0.05)。CAF化疗方案的敏感性为44.1%。TS、ER的表达与CAF化疗方案的敏感性有相关性。结论:TS、ER的过表达可能在乳腺癌的发生过程中起重要作用。检测乳腺癌组织中TS、ER的表达可指导CAF化疗的选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信